All In Biotech

Drug Trial Radar · NCT05603754

Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis (STRIDES)

A Phase 3, Multicenter, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Lorecivivint 0.07 mg in Subjects With Moderate to Severe Osteoarthritis Pain of the Knee

Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 499 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

499

Actual

Start

Nov 18, 2022

Primary completion

Feb 20, 2024

Study completion Feb 20, 2024

Sponsor

Lead sponsor
Biosplice Therapeutics, Inc.Industry
Sponsor type
Industry
Collaborators
NBCD A/S
First posted
Nov 3, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase 3 study was a multicenter, randomized, double-blind, placebo-controlled study of lorecivivint injected intra-articularly (IA) into the target (most painful) knee joint of moderately to severely symptomatic osteoarthritis (OA) subjects at a single dose of 0.07 mg lorecivivint per 2 mL injection. This study utilized standard outcomes to evaluate the safety and efficacy of lorecivivint.

Conditions

  • Knee Osteoarthritis

Interventions

  • LorecivivintDrug

    One intra-articular injection of 0.07 mg lorecivivint in 2 mL vehicle

  • PlaceboDrug

    One intra-articular injection of 0 mg lorecivivint in 2 mL vehicle

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline OA Pain in the Target Knee as Assessed by Weekly Average of Daily Pain Numeric Rating Scale (NRS) at Week 12Time frame: Baseline to Week 12

Locations

44 sites in 1 country. Site status is shown where the registry gives one.

  • Tucson Orthopaedic Institute

    Tucson, Arizona

  • Core Healthcare Research

    Cerritos, California

  • BioSolutions Clinical Research Center

    La Mesa, California

  • Infinity Clinical Research

    Norco, California

  • Dream Team Clinical Research

    Pomona, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Encompass Clinical Research

    Spring Valley, California

  • Millennium Clinical Trials, LLC

    Thousand Oaks, California

  • Unique Clinical Trials

    Doral, Florida

  • Eastern Research, Inc.

    Hialeah, Florida

  • TecTum Research

    Hollywood, Florida

  • Columbus Clinical Services, LLC

    Miami, Florida

  • AppleMed Research Group, LLC

    Miami, Florida

  • Advance Medical Research Center

    Miami, Florida

  • Health and Life Research Institute, LLC

    Miami, Florida

  • BioMed Research and Medical Center

    Miami, Florida

  • Well Pharma Medical Research, Corp

    Miami, Florida

  • South Florida Research Phase I-IV, Inc.

    Miami Springs, Florida

  • Tampa Pain Relief Center

    Tampa, Florida

  • Premier Medical Associates

    The Villages, Florida

  • Conquest Research, LLC

    Winter Park, Florida

  • Pinnacle Trials, Inc.

    Stockbridge, Georgia

  • Chicago Clinical Research Institute

    Chicago, Illinois

  • MediSphere Medical Research Center, LLC

    Evansville, Indiana

  • DelRicht Research - Mandeville

    Mandeville, Louisiana

  • DelRicht Research

    New Orleans, Louisiana

  • DelRicht Research - Prairieville

    Prairieville, Louisiana

  • DelRicht Research - Rockville

    Rockville, Maryland

  • Skylight Health Research

    Burlington, Massachusetts

  • Oakland Medical Research

    Troy, Michigan

  • Healthcare Research Network

    Hazelwood, Missouri

  • Albuquerque Clinical Trials

    Albuquerque, New Mexico

  • Hightop Medical Research Center

    Cincinnati, Ohio

  • Conrad Clinical Research

    Edmond, Oklahoma

  • DelRicht Research - Tulsa

    Tulsa, Oklahoma

  • Clinical Trials of South Carolina

    Charleston, South Carolina

  • Piedmont Research Partners, LLC

    Fort Mill, South Carolina

  • Health Concepts

    Rapid City, South Dakota

  • Zenos Clinical Research

    Dallas, Texas

  • Synergy Groups Medical, LLC

    Houston, Texas

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.